The Victory® Program (“Program”) is sponsored by Amgen Canada Inc.
(“Amgen”) and administered by McKesson, a third-party service provider, on behalf of Amgen.
Other service providers may be appointed by Amgen to administer the Program from time to time.
The personal information that you and/or your healthcare providers (including your doctor and
pharmacy), insurers, or payers provide to the Program, including your name, contact information,
and prescription information, will be used to manage and administer the Program, including
provision of Program services to you, such as reimbursement assistance and administering,
training or assisting in therapy (e.g. self-injection training), and provision of information
about the Program to you.
Amgen has a legal obligation to report adverse drug events to various local and
international health authorities and to monitor product complaints. Personal information
provided to the Program may be (i) monitored by Amgen or its service providers for
safety-related data and product complaints in order to ensure compliance with these legal
reporting requirements, and (ii) reported to local or international health authorities. Amgen
may contact you or your physician for additional information to fulfill its reporting
obligations. Your personal information may be combined with the information of others who
participate in the Program in order to generate aggregated data that does not contain
identifying information ("Aggregated Data"). Aggregated Data may be used by Amgen and its
service providers to improve and/or refine the Program, to design and implement other patient
programs, and for research purposes, including the identification of trends such as product
utilization, adherence, or outcomes.
For these sole purposes, McKesson may, on a confidential basis, collect your
personal information and share it with your healthcare providers, insurers and/or other payers,
and Amgen and/or Amgen's agents and service providers (e.g. information technology providers).
If, from time to time, another service provider is appointed by Amgen to administer the Program,
your personal information will be transferred to this service provider to ensure the continuity
of the Program services to you. Please note that Amgen and its service providers may store or
process your personal information outside of Canada (including in the United States), where
local laws may require the disclosure of personal information to governmental authorities under
circumstances that are different than those that apply in Canada. In addition, your personal
information may be used or disclosed to third parties when permitted or required by applicable
laws, court orders, or government regulations (collectively, “Applicable Laws”).
Your personal information will be retained only for as long as is needed to fulfill the purposes
for which it was collected and in order to comply with Applicable Laws. Industry-standard
safeguards will be used to protect the security of the personal information that is collected.
You may contact the Program’s Privacy Officer at any time to update or access your personal
information, modify or withdraw your consent (in part or in full), express a privacy-related
concern, or inquire about the privacy practices of the Program (including those related to
foreign processing). The Privacy Officer can be reached by email at privacycanada@amgen.com or by mail at Amgen Canada
Inc., Attn: Chief Privacy Officer, 6775 Financial Drive, Suite 300, Mississauga, ON L5N 0A4.
Please note that if you modify or withdraw your consent, your ability to receive the Program
services may be limited.
